EMEA-002936-PIP01-20
Key facts
Active substance |
Anti-alpha-synuclein human monoclonal antibody
|
Therapeutic area |
Neurology
|
Decision number |
P/0136/2021
|
PIP number |
EMEA-002936-PIP01-20
|
Pharmaceutical form(s) |
Solution for infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
H. Lundbeck A/S
E-mail: tsbr@lundbeck.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|